Xenetic Biosciences amends Pharmsynthez agreement; terminates prior work order, enters new one with $40K payment

Xenetic Biosciences, Inc.

Entered Amendment Number One to Master Service Agreement to terminate the prior Work Order with Pharmsynthez.
Executed a new Second Work Order for XCART technology development services upon written request.
Made a one-time $40,000 payment: $21,000 settles prior obligations, $19,000 creditable against future costs.
No further services under prior Work Order; all future work requires new work orders.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.